Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study

PLoS Medicine(2021)10.1371/journal.pmed.1003605Source: DataRank Database

Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study is a research paper published in PLoS Medicine (2021). On theSindex it has a DataRank of 4.8. It has been cited 123 times, with 115 citing works in its 1-hop citation network.

N/A

4.8DataRank · unranked

Scored on demand from live citation data

Open Access123 citations · 115 citing works in its network

Download PDF

Cite:

Linked data & code

refsnp doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)OA: goldTopics (59)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC)Annotations (2)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 15%Citation Network 85%

Base Score Contribution

0.723

From this paper's citation signal

Citation Network Contribution

4.1

From 104 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 115 citers.

Vitamin D for COVID-19: where are we now?
Nature reviews. Immunology202227 citations11 referencesContributes 0.303
Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study
eLife2021161 citations22 referencesContributes 0.231
Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
BMJ202260 citations29 referencesContributes 0.142
An observational and Mendelian randomisation study on vitamin D and COVID-19 risk in UK Biobank
Scientific Reports202127 citations28 referencesContributes 0.119
Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis
Nutrients202292 citations39 referencesContributes 0.116

Authors (16)

Tomoko Nakanishi ORCID,Vincent Mooser ORCID,David Morrison ORCID,Tala Abdullah ORCID,Olumide Adeleye

Live enrichment

PubMed:34061844 PMC:PMC8168855

Canadian Institutes of Health Research

Grant: 365825; 409511

Medical Research Council

Grant: MC_QA137853

Medical Research Council

Grant: MC_PC_17228

Wellcome Trust

Grant: unidentified

unidentified

Calcul Québec

Lady Davis Institute of the Jewish General Hospital

Public Health Agency of Canada

Canada Excellence Research Chairs, Government of Canada

NIH Foundation

Wellcome Trust

Canadian Foundation for Innovation

Genome Québec

NIHR-BioResource

Cancer Research UK

Compute Canada

Fonds de Recherche du Québec - Santé and Québec Ministry of Health and Social Services

Guy's and St Thomas' NHS Foundation Trust

Canadian Institutes of Health Research

Japan Society for the Promotion of Science

Fonds de Recherche du Québec - Santé

Medical Research Council

goldLicense: CC BY

publisherhttps://dx.plos.org/10.1371/journal.pmed.1003605

Europe_PMChttps://europepmc.org/articles/PMC8168855

Europe_PMChttps://europepmc.org/articles/PMC8168855?pdf=render

https://doi.org/10.1101/2020.09.08.20190975

https://www.medrxiv.org/content/medrxiv/early/2021/03/07/2020.09.08.20190975.full.pdf

Fields of Study

03 medical and health sciences0303 health sciences

MeSH Terms

HumansVitamin D DeficiencyGenetic Predisposition to DiseaseVitamin DHospitalizationSeverity of Illness IndexOdds RatioRisk FactorsCase-Control StudiesCausalityPolymorphism, Single NucleotideDietary SupplementsAdultAgedMiddle AgedFemaleMaleGenome-Wide Association StudyMendelian Randomization AnalysisCOVID-19SARS-CoV-2White People

Keywords

AdultMaleEuropean Continental Ancestry Group610Polymorphism, Single NucleotideSeverity of Illness IndexAdult; Aged; Case-Control Studies; Causality; COVID-19; Dietary Supplements; European Continental Ancestry Group; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Hospitalization; Humans; Male; Mendelian Randomization Analysis; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors; SARS-CoV-2; Severity of Illness Index; Vitamin D; Vitamin D DeficiencyRisk Factors616Odds RatioHumansGenetic Predisposition to DiseaseMendelian Randomization AnalysiPolymorphismVitamin DDietary SupplementAgedSARS-CoV-2Risk FactorRCOVID-19Single NucleotideMendelian Randomization AnalysisMiddle AgedVitamin D DeficiencyCausalityHospitalizationCase-Control StudiesDietary SupplementsMedicineFemaleCase-Control StudieHumanResearch ArticleGenome-Wide Association Study

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 10: 10. No inequality

Additional file 1 of Computational network analysis of host genetic risk variants of severe COVID-19

10.6084/m9.figshare.22600394.v1figshare

Additional file 1 of Computational network analysis of host genetic risk variants of severe COVID-19

10.6084/m9.figshare.22600394figshare

Additional file 4 of Computational network analysis of host genetic risk variants of severe COVID-19

10.6084/m9.figshare.22600406figshare

Additional file 4 of Computational network analysis of host genetic risk variants of severe COVID-19

10.6084/m9.figshare.22600406.v1figshare

Additional file 3 of Computational network analysis of host genetic risk variants of severe COVID-19

10.6084/m9.figshare.22600403figshare